Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content

This publication has 31 references indexed in Scilit:

• Plasma Concentration of Apolipoprotein E in Intermediate-Sized Remnant-Like Lipoproteins in Normolipidemic and Hyperlipidemic Subjects
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report
  Atherosclerosis, 1994
• Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E
  Atherosclerosis, 1990
• Cellular metabolism of human plasma intermediate-density lipoprotein (IDL)
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration
  Atherosclerosis, 1989
• Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.
  Journal of Clinical Investigation, 1988
• Familial apolipoprotein E deficiency.
  Journal of Clinical Investigation, 1986
• Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
  Journal of Clinical Investigation, 1986
• Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein Cholesterol
  New England Journal of Medicine, 1983
• Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee.
  Circulation, 1979